These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2114375

  • 1. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice.
    Sharkey RM, Motta-Hennessy C, Gansow OA, Brechbiel MW, Fand I, Griffiths GL, Jones AL, Goldenberg DM.
    Int J Cancer; 1990 Jul 15; 46(1):79-85. PubMed ID: 2114375
    [Abstract] [Full Text] [Related]

  • 2. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M, Schlom J, Gansow OA, Raubitschek A, Mirzadeh S, Brechbiel MW, Colcher D.
    J Nucl Med; 1989 May 15; 30(5):672-82. PubMed ID: 2785585
    [Abstract] [Full Text] [Related]

  • 3. Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies.
    Roselli M, Schlom J, Gansow OA, Brechbiel MW, Mirzadeh S, Pippin CG, Milenic DE, Colcher D.
    Int J Rad Appl Instrum B; 1991 May 15; 18(4):389-94. PubMed ID: 1864727
    [Abstract] [Full Text] [Related]

  • 4. Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.
    Williams LE, Lewis MR, Bebb GG, Clarke KG, Odom-Maryon TL, Shively JE, Raubitschek AA.
    Bioconjug Chem; 1998 May 15; 9(1):87-93. PubMed ID: 9460550
    [Abstract] [Full Text] [Related]

  • 5. Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).
    Camera L, Kinuya S, Garmestani K, Brechbiel MW, Wu C, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH.
    Eur J Nucl Med; 1994 Jul 15; 21(7):640-6. PubMed ID: 7957350
    [Abstract] [Full Text] [Related]

  • 6. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL, Govindan SV, Sharkey RM, Fisher DR, Goldenberg DM.
    J Nucl Med; 2003 Jan 15; 44(1):77-84. PubMed ID: 12515879
    [Abstract] [Full Text] [Related]

  • 7. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques.
    Lee YC, Washburn LC, Sun TT, Byrd BL, Crook JE, Holloway EC, Steplewski Z.
    Cancer Res; 1990 Aug 01; 50(15):4546-51. PubMed ID: 2164441
    [Abstract] [Full Text] [Related]

  • 8. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer.
    Watanabe N, Oriuchi N, Endo K, Inoue T, Kuroki M, Matsuoka Y, Tanada S, Murata H, Kim EE, Sasaki Y.
    J Nucl Med; 2000 Feb 01; 41(2):337-44. PubMed ID: 10688120
    [Abstract] [Full Text] [Related]

  • 9. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
    Esteban JM, Schlom J, Gansow OA, Atcher RW, Brechbiel MW, Simpson DE, Colcher D.
    J Nucl Med; 1987 May 01; 28(5):861-70. PubMed ID: 3106595
    [Abstract] [Full Text] [Related]

  • 10. Labeling of monoclonal antibody conjugates with 90Y.
    Motta-Hennessy C, Sharkey RM, Goldenberg DM.
    Int J Rad Appl Instrum A; 1991 May 01; 42(5):421-6. PubMed ID: 1646187
    [Abstract] [Full Text] [Related]

  • 11. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M, Becker W, Gotthardt M, Angerstein C, Behr TM.
    Eur J Nucl Med Mol Imaging; 2003 Aug 01; 30(8):1140-6. PubMed ID: 12768330
    [Abstract] [Full Text] [Related]

  • 12. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb 01; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 13. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG, Beatty BG, Vlahos WG, Porudominsky D, Philben VJ, Williams LE, Paxton RJ, Shively JE, Beatty JD.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [Abstract] [Full Text] [Related]

  • 14. Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
    Ito T, Qiu H, Collins JA, Brill AB, Johnson DK, Griffin TW.
    Cancer Res; 1991 Jan 01; 51(1):255-60. PubMed ID: 1988087
    [Abstract] [Full Text] [Related]

  • 15. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo].
    Sun B.
    Kaku Igaku; 1994 May 01; 31(5):473-87. PubMed ID: 8028219
    [Abstract] [Full Text] [Related]

  • 16. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
    Slinkin MA, Curtet C, Faivre-Chauvet A, Sai-Maurel C, Gestin JF, Torchilin VP, Chatal JF.
    Nucl Med Biol; 1993 May 01; 20(4):443-52. PubMed ID: 8504286
    [Abstract] [Full Text] [Related]

  • 17. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM, Kaltovich FA, Shih LB, Fand I, Govelitz G, Goldenberg DM.
    Cancer Res; 1988 Jun 01; 48(11):3270-5. PubMed ID: 3365705
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
    Camera L, Kinuya S, Garmestani K, Wu C, Brechbiel MW, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH.
    J Nucl Med; 1994 May 01; 35(5):882-9. PubMed ID: 8176477
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
    Sabbah EN, Kadouche J, Ellison D, Finucane C, Decaudin D, Mather SJ.
    Nucl Med Biol; 2007 Apr 01; 34(3):293-304. PubMed ID: 17383579
    [Abstract] [Full Text] [Related]

  • 20. Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting.
    Chinol M, Paganelli G, Sudati F, Meares C, Fazio F.
    Nucl Med Commun; 1997 Feb 01; 18(2):176-82. PubMed ID: 9076775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.